Literature DB >> 31402332

18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?

M Wartski1, A Sauvanet2.   

Abstract

Pancreatic ductal adenocarcinoma represents 90% of all pancreatic tumors. The only hope for prolonged survival in patients with this condition still remains surgery with complete R0 resection. Initial imaging has a pivotal role to identify patients who are eligible to curative surgery and those who may benefit of neoadjuvant chemotherapy. This review provides an analysis of the recent literature on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in pancreatic adenocarcinoma. Performances of FDG PET in the detection of lymph node involvement and metastatic spread at initial staging and those in the assessment of response to treatment are described.
Copyright © 2019 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  18F-Fluorodeoxyglucose positron emission tomography (FDG PET/CT); Imaging; Pancreatic adenocarcinoma

Mesh：

Substances：

Year:  2019        PMID： 31402332     DOI： 10.1016/j.diii.2019.07.006

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN： 2211-5684            Impact factor:   4.026


  6 in total

Review 1.  CT and MRI of pancreatic tumors: an update in the era of radiomics.

Authors:  Marion Bartoli; Maxime Barat; Anthony Dohan; Sébastien Gaujoux; Romain Coriat; Christine Hoeffel; Christophe Cassinotto; Guillaume Chassagnon; Philippe Soyer
Journal:  Jpn J Radiol       Date:  2020-10-21       Impact factor: 2.374

Review 2.  CT, MRI and PET/CT features of abdominal manifestations of cutaneous melanoma: a review of current concepts in the era of tumor-specific therapies.

Authors:  Maxime Barat; Sarah Guegan-Bart; Anne-Ségolène Cottereau; Enora Guillo; Christine Hoeffel; Maximilien Barret; Sébastien Gaujoux; Anthony Dohan; Philippe Soyer
Journal:  Abdom Radiol (NY)       Date:  2020-11-02

Review 3.  Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon.

Authors:  Anna La Salvia; Irene Persano; Elena Parlagreco; Alessandro Audisio; Massimiliano Cani; Maria Pia Brizzi
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

4.  The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study.

Authors:  Carmelo Caldarella; Fabrizio Cocciolillo; Silvia Taralli; Margherita Lorusso; Valentina Scolozzi; Daniele Antonio Pizzuto; Maria Lucia Calcagni; Vittoria Rufini; Davide Guido; Fernando Palluzzi; Luciano Giacò; Alessandro Giordano; Lucia Leccisotti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-08       Impact factor: 9.236

5.  The Application of [68Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models.

Authors:  He Zhang; Jiaze An; Pengpeng Wu; Caiqin Zhang; Yong Zhao; Dengxu Tan; Changhong Shi; Xu Ge
Journal:  Contrast Media Mol Imaging       Date:  2022-08-05       Impact factor: 3.009

6.  Has the non-resection rate decreased during the last two decades among patients undergoing surgical exploration for pancreatic adenocarcinoma?

Authors:  C Mattevi; J Garnier; U Marchese; J Ewald; M Gilabert; F Poizat; G Piana; J R Delpero; O Turrini
Journal:  BMC Surg       Date:  2020-08-05       Impact factor: 2.102
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.